COMMUNIQUÉS West-GlobeNewswire

Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026
01/11/2026
MINNEAPOLIS and BRISBANE, Australia, Nov. 01, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, [...]
TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients
01/11/2026
Late-Breaking P4 study, simultaneously published in NEJM, shows CT guidance delivers matched one-year clinical outcomes with shorter procedures, demonstrating pre-procedural CCTA can guide key PCI planning decisions [...]
Chaka Khan Opens Chaka's Plantbaed Café in Serenbe, Georgia, November 1
01/11/2026
New plant-based café brings food, music and community together as the Chaka Khan Foundation expands its mission of inclusion through charitable giving and a new playground communication board SERENBE, Ga., Nov. 01, 2026 [...]
Dr. Myung Ju Lee Presents Hybrid Deep Plane Facelift Technique for Nasolabial Fold Correction at ISAPS 2026
31/10/2026
The technique aims to improve correction of pronounced nasolabial folds, a persistent challenge in deep plane facelift surgery CANCÚN, Mexico, Oct. 31, 2026 (GLOBE NEWSWIRE) -- Dr. Myung Ju Lee , founder and medical [...]
Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
30/10/2026
MALVERN, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
Dyadic to Report Q3 2026 Financial Results and Host Conference Call on Thursday November 12, 2026
30/10/2026
JUPITER, Fla., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (Nasdaq: DYAI), a global biotechnology company focused on the [...]
Nathan Fielder Meets Ryan ElHosseiny: The Science Behind “The Strip Club” and “Who’s on First” in You Can See Everything
30/10/2026
MIAMI, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Ryan “Egypt” ElHosseiny, brings over 20 years of laboratory diagnostics experience to Nathan Fielder's You Can See Everything . His new short film, Lab Stripping , reveals the [...]
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30/10/2026
VANCOUVER, BC and BOSTON, MA, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and [...]
Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab
30/10/2026
New fixed, single-room configuration is designed to make DeepOCT+NIRS Imaging and X1-FFR physiology readily available for efficient cath lab workflows At TCT 2026, Philips will showcase its broader full picture [...]
SRX Global Provides Update on Balance Sheet and Share Buyback
30/10/2026
NORTH PALM BEACH, Fla., Oct. 30, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in [...]
Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
30/10/2026
WOODCLIFF LAKE, N.J., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has adopted an amendment (the “ [...]
TME Pharma Publishes Its Semi Annual Results and Half-Year Report
30/10/2026
TME Pharma Publishes Its Semi Annual Results and Half-Year Report Berlin, Germany , October 30, 2026, 18:00 CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotech-company with clinical assets for brain cancer [...]
TME Pharma publie ses résultats semestriels et son rapport semestriel
30/10/2026
TME Pharma publie ses résultats semestriels et son rapport semestriel Berlin, Allemagne, le 30 octobre 2026, 18 h 00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de biotechnologie disposant d' [...]
Halloween Peptide Sale 2026: Kylo Peptides Announces $1 Research Vial Sale With Orders of $200 or More
30/10/2026
SHERIDAN, Wyo., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides [ https://kylopeptides.com/ ], a U.S. research peptides supplier, today announced a limited-time Halloween sale. Customers who place an order of $200 or [...]
Boehringer Ingelheim registers Phase III trial investigating verducatib in COPD
30/10/2026
The Phase III AIRWARD™ trial was published today on ClinicalTrials.gov (NCT07907991). 1 AIRWARD will evaluate the efficacy and safety of verducatib, an investigational oral therapy for COPD. 1 The Phase III trial will [...]
Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
30/10/2026
First FDA-approved biologic specifically designed to cross blood-brain barrier wins award dedicated to exceptional scientific leadership and transformational impact on patient care First new FDA-approved treatment [...]
Why Kraig Labs’ Spider Silk Could Have a Future in Aerospace
30/10/2026
An Equipment Innovator’s Interest in Kraig’s High Tech Fibers Indicates Potential Applications for Lightweight and/or Tough Materials, and Possibly Elevate Project Atlas DENVER, Oct. 30, 2026 (GLOBE NEWSWIRE) -- ( www. [...]
NeOnc’s Ambitious Brain Cancer Plans are Setting the Stage
30/10/2026
500 Patients, 30 Hospitals, 3 Countries is Part of the Setup DENVER, Oct. 30, 2026 (GLOBE NEWSWIRE) -- ( 247MarketNews.com ) — In a market where the latest whizbang trends often dominate investor attention, NeOnc [...]
Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin
30/10/2026
Strategic Combination Brings Highly Innovative Late-Stage D-Fi Franchise Targeting Rare Diseases, with Orphan Drug-Designated Lead Indication in Dystrophic Epidermolysis Bullosa (DEB) Combines Two Complementary [...]

Pages